JangoBio Develops Stem Cell Therapy for Hormone Replacement

MADISON, Wis., Feb. 1, 2022 /PRNewswire/ — JangoBio, LLC announces a breakthrough in the development of a sustainable stem-cell based therapy to replenish circulating hormones back to youthful levels. Using injectable organoids comprised of multiple stem cell types, research scientists…

No Comments

No comments yet.

Sorry, the comment form is closed at this time.